vaistinė Vaigreda - Company finances
|
EUR
|
2018
From: 2018-01-01
To: 2018-12-31
|
2019
From: 2019-01-01
To: 2019-12-31
|
2020
From: 2020-01-01
To: 2020-12-31
|
2021
From: 2021-01-01
To: 2021-12-31
|
2022
From: 2022-01-01
To: 2022-12-31
|
2023
From: 2023-01-01
To: 2023-12-31
|
2024
From: 2024-01-01
To: 2024-12-31
|
2025
From: 2025-01-01
To: 2025-12-31
|
|---|---|---|---|---|---|---|---|---|
|
Financial data
|
||||||||
| Sales revenue | 841,737 | 991,319 | 1,319,425 | 1,333,142 | 1,327,101 | 1,504,455 | 1,303,007 | 1,368,475 |
| Profit before tax | 30,086 | 32,909 | 87,038 | 73,462 | 46,366 | 23,072 | 38,145 | 14,354 |
| Net profit | 25,157 | 27,685 | 73,226 | 61,821 | 38,404 | 18,977 | 31,914 | 11,263 |
| Equity | 138,032 | 147,717 | 194,943 | 220,764 | 209,169 | 188,145 | 220,059 | 191,322 |
| Liabilities | 161,420 | 190,522 | 218,213 | 217,731 | 170,525 | 205,343 | 165,828 | 175,327 |
| Non-current assets | 59,918 | 51,041 | 43,750 | 36,460 | 29,169 | 22,818 | 18,724 | 15,053 |
| Current assets | 239,094 | 286,739 | 369,154 | 401,780 | 349,819 | 369,931 | 366,500 | 351,401 |
| Total assets | 299,012 | 337,780 | 412,904 | 438,240 | 378,988 | 392,749 | 385,224 | 366,454 |
|
Taxes paid
|
||||||||
| STI taxes | - | - | - | - | - | 68,946 | 55,434 | 57,045 |
| Social insurance contributions | - | - | - | - | - | 41,141 | 39,740 | 43,463 |
|
Financial indicators
|
||||||||
| Revenue change y/y | +1.6% | +17.8% | +33.1% | +1.0% | -0.5% | +13.4% | -13.4% | +5.0% |
| ROA Return on Assets (ROA). The ratio of net profit to assets. Indicates the company's efficiency. | 8.4% | 8.2% | 17.7% | 14.1% | 10.1% | 4.8% | 8.3% | 3.1% |
| ROE Return on equity. The ratio of net profit to equity. Shows the return to shareholders. | 18.2% | 18.7% | 37.6% | 28.0% | 18.4% | 10.1% | 14.5% | 5.9% |
| Profit margin Net profit margin. Shows the overall profitability of the company. | 3.0% | 2.8% | 5.5% | 4.6% | 2.9% | 1.3% | 2.4% | 0.8% |
| EBT% EBT (Earnings Before Taxes) to revenue ratio. Shows the overall profitability of the company. | 3.6% | 3.3% | 6.6% | 5.5% | 3.5% | 1.5% | 2.9% | 1.0% |
| Liabilities/Equity The debt-to-equity ratio shows the company's capital structure. | 1.2 | 1.3 | 1.1 | 1.0 | 0.8 | 1.1 | 0.8 | 0.9 |
| Revenue per employee Ratio of revenue to the average annual number of employees. Indicates company efficiency. | 84,174 | 106,213 | 158,332 | 152,359 | 185,176 | 214,922 | 186,144 | 195,496 |
Sales revenue
See Scoris data in Google Search
Mark Scoris as a favorite source. One click, no registration.
vaistinė Vaigreda - Social security debts
| From | To | Debt, € |
|---|---|---|
| 2022-07-25 | 2022-08-04 | 0.19 |
| 2022-03-16 | 2022-03-17 | 209.51 |
| 2022-01-28 | 2022-02-07 | 0.74 |
| 2021-12-16 | 2021-12-19 | 492.71 |
vaistinė Vaigreda - VMI tax arrears
The company had no tax arrears (debts) to the State Tax Inspectorate
VMI debt information has been collected since 2024-10-07. Debts for older periods will not be displayed.
Analysis of the company's financial position
This description was generated by artificial intelligence.
Report if inaccurate.
Vaigreda, UAB (code 166821721) is a Private Limited Liability Company operating in retail sale of pharmaceutical products. In 2025, the company generated revenue of €1.37M, up 5.0% year on year, while net profit declined to €11.3K from €31.9K in 2024. This followed a revenue peak of €1.50M in 2023 and a lower level in 2024, showing a two-year decline in sales with a partial recovery in 2025. Profitability weakened during the latest year, with a net profit margin of 0.8% versus 2.4% in 2024 and 1.3% in 2023. The balance sheet remained moderate in size, with total assets of €366.5K, equity of €191.3K and liabilities of €175.3K at year-end 2025. Equity accounted for 52.2% of assets, while debt to equity stood at 0.92. Return on equity was 5.9% and return on assets 3.1%. Asset turnover was 3.73x, indicating relatively efficient use of the asset base. Revenue per employee was €195.5K, while profit per employee was €1.6K.